Join Us in Boston for Discovery On Target 2024!

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

We aim to meet your research needs. Visit numerous concurrent sessions all week for informative presentations, lively dialogue, and meaningful connections with peers. Customize your experience further through focused short courses, training seminars, interactive breakout discussions, and networking options that help you engage with experts and solutions providers.

Our four-day event brings back popular topics like kinases, immunomodulation, and degraders, plus new coverage of covalent chemistries and induced proximity, synthetic biology, cancer antibodies, generative AI, and translational models.


Discovery on Target 2024 by the Numbers

1,100+

Attendees

275

Presentations

100+

Research Posters

13

Conference Tracks

4

Symposia

1

In-Person Training Seminar

In-Person Short Courses

90

Exhibitors

22

Countries Represented

As of 2/19/24

2023 Premier Sponsors

CausalyCharles-River  GenScript-ProBio

View All Sponsors


2024 Plenary Keynote Program


Richard DiMarchi, PhD

Richard DiMarchi, PhD
Distinguished Professor of Chemistry and Chair, Biomolecular Sciences, Indiana University; former Executive, Lilly and Novo Research Labs


Stephen W. Fesik, PhD

Stephen W. Fesik, PhD
Professor of Biochemistry, Pharmacology & Chemistry; Orrin H. Ingram II Chair in Cancer Research, Vanderbilt University



Highlights from Discovery on Target 2023





2022 Video Highlights